-+ 0.00%
-+ 0.00%
-+ 0.00%

Chi-Med announced today that solepinib has been certified as an orphan drug by the US Food and Drug Administration to treat autoimmune hemolytic anemia. Solepinib is a novel, highly selective oral spleen tyrosine kinase inhibitor.

Zhitongcaijing·11/05/2026 00:46:52
Listen to the news
Chi-Med announced today that solepinib has been certified as an orphan drug by the US Food and Drug Administration to treat autoimmune hemolytic anemia. Solepinib is a novel, highly selective oral spleen tyrosine kinase inhibitor.